Abiopharma

Silence Therapeutics - Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

Plug Reports Revenue of ~$178 Million, ~Break-Even Gross Margin, Net Cash Usage of ~$61 Million and Increases Revenue Guidance for 2026

InspireMD to Announce Second Quarter 2026 Financial Results

NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital

Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)